Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
1.81
Nov 19 • 3:59 PM ET Dollar change0.00 Percentage change(0.00%)
Aftermarket Close
1.81
Aftermarket • 4:15 PM ET Dollar change0.00 Percentage change(0.00%)
Index
-
Market Cap
20.95M
Enterprise Value
15.78M
Income
0.12M
Sales
3.75M
Book/sh
2.39
Cash/sh
0.90
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
1
IPO
Jan 03, 2002
P/E
177.45
Forward P/E
-
PEG
-
P/S
5.59
P/B
0.76
P/C
2.00
P/FCF
6.29
EV/EBITDA
-
EV/Sales
4.21
Quick Ratio
2.87
Current Ratio
2.87
Debt/Eq
0.19
LT Debt/Eq
0.15
Option/Short
Yes / Yes
EPS (ttm)
0.01
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
83.18% 72.84%
Sales past 3/5Y
-64.91% -45.84%
EPS Y/Y TTM
-59.77%
Sales Y/Y TTM
33.94%
EPS Q/Q
222.14%
Sales Q/Q
60.59%
Insider Own
8.45%
Insider Trans
0.00%
Inst Own
32.12%
Inst Trans
-0.68%
ROA
0.41%
ROE
0.57%
ROIC
0.38%
Gross Margin
49.37%
Oper. Margin
-93.48%
Profit Margin
3.26%
SMA20
0.64%
SMA50
-6.91%
SMA200
-12.81%
Trades
Shs Outstand
11.57M
Shs Float
10.60M
52W High
2.95 -38.64%
52W Low
1.43 26.57%
Volatility
7.72% 4.74%
ATR (14)
0.10
RSI (14)
46.81
Beta
0.61
Rel Volume
0.44
Avg Volume
24.36K
Volume
10,668
Perf Week
-0.55%
Perf Month
-4.74%
Perf Quarter
-12.14%
Perf Half Y
-14.22%
Perf YTD
11.04%
Perf Year
9.70%
Perf 3Y
-20.26%
Perf 5Y
-93.63%
Perf 10Y
-99.47%
Prev Close
1.81
Price
1.81
Change %
0.00%
Consensus
Strong Buy
Avg. Price Target
$5.00
Implied Upside
+176.2%
Analysts11incl. previous ratings
Rating Distribution8 Buy · 2 Hold · 1 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Aug 07, 2020Downgrade
JEF logoJJefferies
Hold → Underperform
May 19, 2020Downgrade
JPM logoJJP Morgan
Overweight → Neutral
Dec 02, 2019Initiated
GGuggenheim
Buy
Oct 17, 2019Initiated
HH.C. Wainwright
Buy$7+286.7%
Apr 30, 2019Resumed
NNoble Capital Markets
Outperform$13+618.2%
Jun 15, 2018Initiated
JPM logoJJP Morgan
Overweight$11+507.7%
Sep 08, 2017Initiated
MS logoMMorgan Stanley
Equal-Weight$6+231.5%
Jul 11, 2017Upgrade
OPY logoOOppenheimer
Perform → Outperform
May 09, 2017Downgrade
OPY logoOOppenheimer
Outperform → Perform
Nov 22, 2016Resumed
JEF logoJJefferies
Buy$18+894.5%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Thompson Tommy GDirectorDec 23 '25Buy1.678,40014,03123,179Dec 29 04:23 PM
TherapeuticsMD, Inc. operates as a pharmaceutical company. The firm engages in licensing pharmaceutical products and collecting royalties. Its brands include BIJUVA, IMVEXXY, and ANNOVERA. The company was founded by Robert G. Finizio and Brian A. Bernick in 1907 and is headquartered in Boca Raton, FL.
Chief Executive OfficerMr. Marlan D. Walker J.D.
Principal Financial & Accounting OfficerMr. Joseph A. Ziegler